Rockwell Medical Technologies (RMTI) Tops Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Rockwell Medical Technologies (RMTI) Tops Q1 EPS by 3c

Rockwell Medical Reports First Quarter 2015 Results

May 7, 2015 4:01 PM EDT

WIXOM, Mich., May 7, 2015 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, reported results for the first quarter of 2015.

Q1 2015 Financial Highlights

Sales were $13.9 million, a 7.1% increase over Q1 2014. Gross profit was $2.3 million, a 37.6% increase over Q1 2014. Gross profit margins increased to 16.7% compared to 13.0% in Q1 2014. R&D expense was $0.8 million, a $3.8 million or 83% decrease... More